Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Aug 15, 2024; 16(8): 3559-3584
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3559
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3559
Figure 2 The effect of miR-491-5p in gastric cancer.
A: The targeting relationship between CASC19 and miR-491-5p by dual luciferase reporter experiments; B: The expression of miR-491-5p after knock down of CASC19; C: The effect of miR-491-5p on the proliferation of gastric cancer cells by cell counting kit-8 assay; D and E: The consequence of apoptosis result by miR-491-5p mimics and miR-491-5p inhibitor; F: The change of apoptosis-related proteins by miR-491-5p mimics and miR-491-5p inhibitor through western blot experiment; G: The change of epithelial-mesenchymal transition proteins by miR-491-5p mimics and miR-491-5p inhibitor through western blot experiment. aP < 0.05, bP < 0.01, cP < 0.001, dP < 0.05 was compared with the control group respectively. P < 0.05 was considered statistically significant.
- Citation: Zhang LX, Luo PQ, Wei ZJ, Xu AM, Guo T. Expression and significant roles of the long non-coding RNA CASC19/miR-491-5p/HMGA2 axis in the development of gastric cancer. World J Gastrointest Oncol 2024; 16(8): 3559-3584
- URL: https://www.wjgnet.com/1948-5204/full/v16/i8/3559.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i8.3559